Head to head
Arrowhead Pharmaceuticals, Inc. (ARWR)vsRegeneron Pharmaceuticals, Inc. (REGN)
Price & valuation
| Metric | ARWR | REGN |
|---|---|---|
| Price | $88.70 | $651.18 |
| Change | +19.03% | -3.56% |
| Market cap | — | — |
| P/E ratio | — | — |
| EPS | — | — |
| 52-week high | — | — |
| 52-week low | — | — |
| Volume | 6,988,383 | 872,124 |
Latest annual financials
| Metric | ARWR | REGN |
|---|---|---|
| Revenue | $829.45M | $14.34B |
| Net income | -$1.63M | $4.5B |
| EPS | -$0.01 | $41.48 |